Correlation Between Ford and Molecular Pharmacology

Can any of the company-specific risk be diversified away by investing in both Ford and Molecular Pharmacology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ford and Molecular Pharmacology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ford Motor and Molecular Pharmacology, you can compare the effects of market volatilities on Ford and Molecular Pharmacology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ford with a short position of Molecular Pharmacology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ford and Molecular Pharmacology.

Diversification Opportunities for Ford and Molecular Pharmacology

0.0

Correlation Coefficient

Ford  Molecular Pharmacology

Pay attention - limited upside

The 3 months correlation between Ford and Molecular is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ford Motor and Molecular Pharmacology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Pharmacology and Ford is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ford Motor are associated (or correlated) with Molecular Pharmacology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Pharmacology has no effect on the direction of Ford i.e., Ford and Molecular Pharmacology go up and down completely randomly.

Pair Corralation between Ford and Molecular Pharmacology

Taking into account the 90-day investment horizon Ford Motor is expected to under-perform the Molecular Pharmacology. But the stock apears to be less risky and, when comparing its historical volatility, Ford Motor is 27.09 times less risky than Molecular Pharmacology. The stock trades about -0.01 of its potential returns per unit of risk. The Molecular Pharmacology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Molecular Pharmacology on October 24, 2024 and sell it today you would earn a total of  0.00  from holding Molecular Pharmacology or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Ford Motor  vs.  Molecular Pharmacology

Ford Motor

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ford Motor has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Molecular Pharmacology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Molecular Pharmacology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Molecular Pharmacology is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Ford and Molecular Pharmacology

The main advantage of trading using opposite Ford and Molecular Pharmacology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ford position performs unexpectedly, Molecular Pharmacology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Pharmacology will offset losses from the drop in Molecular Pharmacology's long position.

The idea behind Ford Motor and Molecular Pharmacology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..